LianBio expected to post a loss of 28 cents a share - Earnings Preview

LianBio

09/08/2023 21:17

* LianBio  LIAN.OQ   LIAN.O  is expected to show no change
in
quarterly revenue when it reports  results on August 11
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for LianBio is for a
loss
of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for LianBio is
$6.5​,
above​ its last closing price of $1.85. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.28       -0.27      -0.22     Beat    19.3
 Dec. 31 2023  -0.05       -0.27      -0.17     Beat    37.6
 Sep. 30 2022  -0.41       -0.39      -0.20     Beat    49​
 Jun. 30 2022  -0.28       -0.27      -0.39     Missed  -41.8
 ​​Mar.        -0.27       -0.30      -0.26     Beat    12.6
 31 2022                                                
 Dec. 31 2021  -1.16       -0.71      -0.28     Beat    60.8​
 Sep. 30 2021  -0.58       -0.57      -0.63     Missed  -9.6
 This summary was machine generated August 9 at 20:17 GMT.  All
figures in US dollars  unless otherwise stated